DOSSIER · 13F-HR · Q2 2026

ACORN CAPITAL ADVISORS, LLC

$366M in tracked AUM across 20 positions as of Q2 2026.

AC
CIK 0002054410 · last filed Jun 30, 2026
Total AUM
$366M
as of Q2 2026
Holdings
20
positions
Whale Score
71
71
strong
Activity
no data
changes this Q
AI Analysis · Q2 2026

ACORN CAPITAL ADVISORS, LLC filed its latest 13F-HR for Q2 2026. See the latest holdings and position changes below.

Quarter at a glance — Q2 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q2 2026.

#HoldingValueSharesWeight
01
CGON
CG ONCOLOGY INC
$80M1.1M21.9%
02
M96088105
UROGEN PHARMA LTD
$62M1.7M16.8%
03
TRVI
TREVI THERAPEUTICS INC
$40M2.1M10.9%
04
CADL
CANDEL THERAPEUTICS INC
$36M3.5M9.8%
05
PBYI
PUMA BIOTECHNOLOGY INC
$34M4.1M9.1%
06
JBIO
JADE BIOSCEINCES INC
$22M987K6.0%
07
BCAX
BICARA THERAPEUTICS
$19M643K5.2%
08
KPTI
KARYOPHARM THERAPEUTICS INC
$15M1.5M4.0%
09
OKUR
ONKURE THERAPEUTICS INC
$13M2.8M3.5%
10
HELP
HELUS PHARMA INC.
$10M1.5M2.8%

Filing history

2026Q2Jun 30
$366M 4.2%
20 positionsView →
2026Q1Mar 31
$352M 19.2%
22 positionsView →
2025Q4Dec 31
$295M 49.8%
21 positionsView →
2025Q3Sep 30
$197M 28.8%
20 positionsView →
2025Q2Jun 30
$153M 91.7%
21 positionsLocked
2025Q1Mar 31
$80M 56.9%
15 positionsLocked
2024Q4Dec 31
$185M
20 positionsLocked